Microbial Peptidyl-Prolyl cis/trans Isomerases (PPIases): Virulence factors and potential alternative drug targets

Microbiology and Molecular Biology Reviews

Volumn 78, Issue 3, 2014, Pages 544-571

  Ünal, Can M ^a,b   Steinert, Michael ^b,c  

^a TURKISH GERMAN UNIVERSITY   (Turkey)

^b TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; MACROPHAGE INFECTIVITY POTENTIATOR; PEPTIDYLPROLYL ISOMERASE; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG; VIRULENCE FACTOR; ANTIINFECTIVE AGENT; ANTIPARASITIC AGENT; BACTERIAL PROTEIN; ENZYME INHIBITOR; PROTOZOAL PROTEIN;

BACTERIAL VIRULENCE; BURKHOLDERIA PSEUDOMALLEI; CELLULAR DISTRIBUTION; COVALENT BOND; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; LEGIONELLA PNEUMOPHILA; MOLECULAR DOCKING; NONHUMAN; PARASITE VIRULENCE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; STEREOSPECIFICITY; ANIMAL; ANTAGONISTS AND INHIBITORS; BACTERIAL INFECTIONS; GENETICS; MICROBIOLOGY; PARASITIC DISEASES; PARASITOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIPARASITIC AGENTS; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; ENZYME INHIBITORS; HUMANS; PARASITIC DISEASES; PEPTIDYLPROLYL ISOMERASE; PROTOZOAN PROTEINS; VIRULENCE FACTORS;

EID: 84907214682     PISSN: 10922172     EISSN: 10985557     Source Type: Journal    
DOI: 10.1128/MMBR.00015-14     Document Type: Review

References (296)

1. Göthel SF, Marahiel MA. 1999. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cell. Mol. Life Sci. 55:423-436. http://dx.doi.org/10.1007/s000180050299.
2. Brandts JF, Halvorson HR, Brennan M. 1975. Consideration of the possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues. Biochemistry (Mosc.) 14:4953-4963. http://dx.doi.org/10.1021/bi00693a026.
3. Cook KH, Schmid FX, Baldwin RL. 1979. Role of proline isomerization in folding of ribonuclease A at low temperatures. Proc. Natl. Acad. Sci. U. S. A. 76:6157-6161. http://dx.doi.org/10.1073/pnas.76.12.6157.
4. Stewart DE, Sarkar A, Wampler JE. 1990. Occurrence and role of cis peptide bonds in protein structures. J. Mol. Biol. 214:253-260. http://dx.doi.org/10.1016/0022-2836(90)90159-J.
5. Schmid FX, Baldwin RL. 1978. Acid catalysis of the formation of the slow-folding species of RNase A: evidence that the reaction is proline isomerization. Proc. Natl. Acad. Sci. U. S. A. 75:4764-4768. http://dx.doi.org/10.1073/pnas.75.10.4764.
6. Fischer G, Heins J, Barth A. 1983. The conformation around the peptide bond between the P1- and P2-positions is important for catalytic activity of some proline-specific proteases. Biochim. Biophys. Acta 742:452-462. http://dx.doi.org/10.1016/0167-4838(83)90261-3.
7. Fischer G, Bang H, Mech C. 1984. Determination of enzymatic catalysis for the cis-trans-isomerization of peptide binding in proline-containing peptides. Biomed. Biochim. Acta 43:1101-1111.
8. Fischer G, Bang H, Berger E, Schellenberger A. 1984. Conformational specificity of chymotrypsin toward proline-containing substrates. Biochim. Biophys. Acta 791:87-97. http://dx.doi.org/10.1016/0167-4838(84)90285-1.
9. Fischer G, Bang H. 1985. The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase. Biochim. Biophys. Acta 828:39-42. http://dx.doi.org/10.1016/0167-4838(85)90006-8.
10. Lang K, Schmid FX, Fischer G. 1987. Catalysis of protein folding by prolyl isomerase. Nature 329:268-270. http://dx.doi.org/10.1038/329268a0.
11. Fischer G, Wittmann-Liebold B, Lang K, Kiefhaber T, Schmid FX. 1989. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337:476-478. http://dx.doi.org/10.1038/337476a0.
12. Takahashi N, Hayano T, Suzuki M. 1989. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 337:473-475. http://dx.doi.org/10.1038/337473a0.
13. Dreyfuss M, Härri E, Hofmann H, Kobel H, Pache W, Tscherter H. 1976. Cyclosporin A and C. Appl. Microbiol. Biotechnol. 3:125-133.
14. Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW. 1984. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226:544-547. http://dx.doi.org/10.1126/science.6238408.
15. Harding MW, Handschumacher RE, Speicher DW. 1986. Isolation and amino acid sequence of cyclophilin. J. Biol. Chem. 261:8547-8555.
16. Harding MW, Galat A, Uehling DE, Schreiber SL. 1989. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341:758-760. http://dx.doi.org/10.1038/341758a0.
17. Siekierka JJ, Hung SH, Poe M, Lin CS, Sigal NH. 1989. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341:755-757. http://dx.doi.org/10.1038/341755a0.
18. Rahfeld JU, Schierhorn A, Mann K, Fischer G. 1994. A novel peptidylprolyl cis/trans isomerase from Escherichia coli. FEBS Lett. 343:65-69. http://dx.doi.org/10.1016/0014-5793(94)80608-X.
19. Rahfeld JU, Rücknagel KP, Schelbert B, Ludwig B, Hacker J, Mann K, Fischer G. 1994. Confirmation of the existence of a third family among peptidyl-prolyl cis/trans isomerases. Amino acid sequence and recombinant production of parvulin. FEBS Lett. 352:180-184.
20. Scholz C, Rahfeld J, Fischer G, Schmid FX. 1997. Catalysis of protein folding by parvulin. J. Mol. Biol. 273:752-762. http://dx.doi.org/10.1006/jmbi.1997.1301.
21. Hennig L, Christner C, Kipping M, Schelbert B, Rücknagel KP, Grabley S, Küllertz G, Fischer G. 1998. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry (Mosc.) 37:5953-5960. http://dx.doi.org/10.1021/bi973162p.
22. Timerman AP, Wiederrecht G, Marcy A, Fleischer S. 1995. Characterization of an exchange reaction between soluble FKBP-12 and the FKBP-ryanodine receptor complex. Modulation by FKBP mutants deficient in peptidyl-prolyl isomerase activity. J. Biol. Chem. 270:2451-2459.
23. Behrens S, Maier R, de Cock H, Schmid FX, Gross CA. 2001. The SurA periplasmic PPIase lacking its parvulin domains functions in vivo and has chaperone activity. EMBO J. 20:285-294. http://dx.doi.org/10.1093/emboj/20.1.285.
24. Kramer G, Patzelt H, Rauch T, Kurz TA, Vorderwülbecke S, Bukau B, Deuerling E. 2004. Trigger factor peptidyl-prolyl cis/ trans isomerase activity is not essential for the folding of cytosolic proteins in Escherichia coli. J. Biol. Chem. 279:14165-14170. http://dx.doi.org/10.1074/jbc.M313635200.
25. Gerard M, Deleersnijder A, Demeulemeester J, Debyser Z, Baekelandt V. 2011. Unraveling the role of peptidyl-prolyl isomerases in neurodegeneration. Mol. Neurobiol. 44:13-27. http://dx.doi.org/10.1007/s12035-011-8184-2.
26. Göthel SF, Scholz C, Schmid FX, Marahiel MA. 1998. Cyclophilin and trigger factor from Bacillus subtilis catalyze in vitro protein folding and are necessary for viability under starvation conditions. Biochemistry (Mosc.) 37:13392-13399. http://dx.doi.org/10.1021/bi981253w.
27. Justice SS, Hunstad DA, Harper JR, Duguay AR, Pinkner JS, Bann J, Frieden C, Silhavy TJ, Hultgren SJ. 2005. Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia coli. J. Bacteriol. 187:7680-7686. http://dx.doi.org/10.1128/JB.187.22.7680-7686.2005.
28. Dolinski K, Muir S, Cardenas M, Heitman J. 1997. All cyclophilins and FK506 binding proteins are, individually and collectively, dispensable for viability in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 94:13093-13098. http://dx.doi.org/10.1073/pnas.94.24.13093.
29. Obi IR, Nordfelth R, Francis MS. 2011. Varying dependency of periplasmic peptidylprolyl cis-trans isomerases in promoting Yersinia pseudotuberculosis stress tolerance and pathogenicity. Biochem. J. 439:321-332. http://dx.doi.org/10.1042/BJ20110767.
30. Harrison RK, Stein RL. 1990. Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes. Biochemistry (Mosc.) 29:3813-3816. http://dx.doi.org/10.1021/bi00468a001.
31. Fischer G, Bang H, Ludwig B, Mann K, Hacker J. 1992. Mip protein of Legionella pneumophila exhibits peptidyl-prolyl-cis/trans isomerase (PPIase) activity. Mol. Microbiol. 6:1375-1383. http://dx.doi.org/10.1111/j.1365-2958.1992.tb00858.x.
32. Yaffe MB, Schutkowski M, Shen M, Zhou XZ, Stukenberg PT, Rahfeld JU, Xu J, Kuang J, Kirschner MW, Fischer G, Cantley LC, Lu KP. 1997. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 278:1957-1960. http://dx.doi.org/10.1126/science.278.5345.1957.
33. McNaughton L, Li Z, Van Roey P, Hanes SD, LeMaster DM. 2010. Restricted domain mobility in the Candida albicans Ess1 prolyl isomerase. Biochim. Biophys. Acta 1804:1537-1541. http://dx.doi.org/10.1016/j.bbapap.2010.03.005.
34. Scholz C, Mücke M, Rape M, Pecht A, Pahl A, Bang H, Schmid FX. 1998. Recognition of protein substrates by the prolyl isomerase trigger factor is independent of proline residues. J. Mol. Biol. 277:723-732. http://dx.doi.org/10.1006/jmbi.1997.1604.
35. D'Andrea LD, Regan L. 2003. TPR proteins: the versatile helix. Trends Biochem. Sci. 28:655-662. http://dx.doi.org/10.1016/j.tibs.2003.10.007.
36. Schiene-Fischer C, Aumüller T, Fischer G. 2013. Peptide bond cis/trans isomerases: a biocatalysis perspective of conformational dynamics in proteins. Top. Curr. Chem. 328: 35-67. http://dx.doi.org/10.1007/128-2011-151.
37. Blackburn EA, Walkinshaw MD. 2011. Targeting FKBP isoforms with small-molecule ligands. Curr. Opin. Pharmacol. 11:365-371. http://dx.doi.org/10.1016/j.coph.2011.04.007.
38. Pahl A, Keller U. 1994. Streptomyces chrysomallus FKBP-33 is a novel immunophilin consisting of two FK506 binding domains; its gene is transcriptionally coupled to the FKBP-12 gene. EMBO J. 13:3472-3480.
39. Somarelli JA, Lee SY, Skolnick J, Herrera RJ. 2008. Structure-based classification of 45 FK506-binding proteins. Proteins 72:197-208. http://dx.doi.org/10.1002/prot.21908.
40. Adams B, Musiyenko A, Kumar R, Barik S. 2005. A novel class of dual-family immunophilins. J. Biol. Chem. 280:24308-24314. http://dx.doi.org/10.1074/jbc.M500990200.
41. Krücken J, Greif G, von Samson-Himmelstjerna G. 2009. In silico analysis of the cyclophilin repertoire of apicomplexan parasites. Parasit. Vectors 2:27. http://dx.doi.org/10.1186/1756-3305-2-27.
42. Jakob RP, Zoldák G, Aumüller T, Schmid FX. 2009. Chaperone domains convert prolyl isomerases into generic catalysts of protein folding. Proc. Natl. Acad. Sci. U. S. A. 106:20282-20287. http://dx.doi.org/10.1073/pnas.0909544106.
43. Geitner A-J, Schmid FX. 2012. Combination of the human prolyl isomerase FKBP12 with unrelated chaperone domains leads to chimeric folding enzymes with high activity. J. Mol. Biol. 420:335-349. http://dx.doi.org/10.1016/j.jmb.2012.04.018.
44. Moro A, Ruiz-Cabello F, Fernández-Cano A, Stock RP, González A. 1995. Secretion by Trypanosoma cruzi of a peptidyl-prolyl cis-trans isomerase involved in cell infection. EMBO J. 14:2483-2490.
45. Himukai R, Kuzuhara T, Horikoshi M. 1999. Relationship between the subcellular localization and structures of catalytic domains of FKBP-type PPIases. J. Biochem. 126: 879-888. http://dx.doi.org/10.1093/oxfordjournals.jbchem.a022530.
46. Arora K, Gwinn WM, Bower MA, Watson A, Okwumabua I, Mac-Donald HR, Bukrinsky MI, Constant SL. 2005. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J. Immunol. 175:517-522. http://dx.doi.org/10.4049/jimmunol.175.1.517.
47. Hayano T, Takahashi N, Kato S, Maki N, Suzuki M. 1991. Two distinct forms of peptidylprolyl-cis-trans-isomerase are expressed separately in periplasmic and cytoplasmic compartments of Escherichia coli cells. Biochemistry (Mosc.) 30:3041-3048. http://dx.doi.org/10.1021/bi00226a009.
48. Kim N, Weeks DL, Shin JM, Scott DR, Young MK, Sachs G. 2002. Proteins released by Helicobacter pylori in vitro. J. Bacteriol. 184:6155-6162. http://dx.doi.org/10.1128/JB.184.22.6155-6162.2002.
49. Söderberg MA, Cianciotto NP. 2008. A Legionella pneumophila peptidyl-prolyl cis-trans isomerase present in culture supernatants is necessary for optimal growth at low temperatures. Appl. Environ. Microbiol. 74:1634-1638. http://dx.doi.org/10.1128/AEM.02512-07.
50. Delpino MV, Comerci DJ, Wagner MA, Eschenbrenner M, Mujer CV, Ugalde RA, Fossati CA, Baldi PC, Delvecchio VG. 2009. Differential composition of culture supernatants from wild-type Brucella abortus and its isogenic virB mutants. Arch. Microbiol. 191:571-581. http://dx.doi.org/10.1007/s00203-009-0484-9.
51. Kontinen VP, Sarvas M. 1993. The PrsA lipoprotein is essential for protein secretion in Bacillus subtilis and sets a limit for high-level secretion. Mol. Microbiol. 8:727-737. http://dx.doi.org/10.1111/j.1365-2958.1993.tb01616.x.
52. Dartigalongue C, Raina S. 1998. A new heat-shock gene, ppiD, encodes a peptidyl-prolyl isomerase required for folding of outer membrane proteins in Escherichia coli. EMBO J. 17:3968-3980. http://dx.doi.org/10.1093/emboj/17.14.3968.
53. Helbig JH, Lück PC, Steinert M, Jacobs E, Witt M. 2001. Immunolocalization of the Mip protein of intracellularly and extracellularly grown Legionella pneumophila. Lett. Appl. Microbiol. 32:83-88. http://dx.doi.org/10.1046/j.1472-765x.2001.00861.x.
54. Trémillon N, Morello E, Llull D, Mazmouz R, Gratadoux J-J, Guillot A, Chapot-Chartier M-P, Monlezun L, Solé V, Ginisty H, Poquet I. 2012. PpiA, a surface PPIase of the cyclophilin family in Lactococcus lactis. PLoS One 7:e33516. http://dx.doi.org/10.1371/journal.pone.0033516.
55. Kandror O, Goldberg AL. 1997. Trigger factor is induced upon cold shock and enhances viability of Escherichia coli at low temperatures. Proc. Natl. Acad. Sci. U. S. A. 94:4978-4981. http://dx.doi.org/10.1073/pnas.94.10.4978.
56. Kurek I, Stöger E, Dulberger R, Christou P, Breiman A. 2002. Overexpression of the wheat FK506-binding protein 73 (FKBP73) and the heat-induced wheat FKBP77 in transgenic wheat reveals different functions of the two isoforms. Transgenic Res. 11:373-379. http://dx.doi.org/10.1023/A:1016374128479.
57. Fasseas MK, Dimou M, Katinakis P. 2012. The Caenorhabditis elegans parvulin gene subfamily and their expression under cold or heat stress along with the fkb subfamily. Biochem. Biophys. Res. Commun. 423:520-525. http://dx.doi.org/10.1016/j.bbrc.2012.05.157.
58. Gioti A, Simon A, Le Pêcheur P, Giraud C, Pradier JM, Viaud M, Levis C. 2006. Expression profiling of Botrytis cinerea genes identifies three patterns of up-regulation in planta and an FKBP12 protein affecting pathogenicity. J. Mol. Biol. 358:372-386. http://dx.doi.org/10.1016/j.jmb.2006.01.076.
59. Port GC, Freitag NE. 2007. Identification of novel Listeria monocytogenes secreted virulence factors following mutational activation of the central virulence regulator, PrfA. Infect. Immun. 75:5886-5897. http://dx.doi.org/10.1128/IAI.00845-07.
60. Patterson CE, Schaub T, Coleman EJ, Davis EC. 2000. Developmental regulation of FKBP65. An ER-localized extracellular matrix binding-protein. Mol. Biol. Cell 11:3925-3935. http://dx.doi.org/10.1091/mbc.11.11.3925.
61. Patterson CE, Abrams WR, Wolter NE, Rosenbloom J, Davis EC. 2005. Developmental regulation and coordinate reexpression of FKBP65 with extracellular matrix proteins after lung injury suggest a specialized function for this endoplasmic reticulum immunophilin. Cell Stress Chaperones 10:285-295. http://dx.doi.org/10.1379/CSC-118R.1.
62. Steiner JP, Dawson TM, Fotuhi M, Glatt CE, Snowman AM, Cohen N, Snyder SH. 1992. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 358:584-587. http://dx.doi.org/10.1038/358584a0.
63. Wang W-W, Ma Q, Xiang Y, Zhu S-W, Cheng B-J. 2012. Genome-wide analysis of immunophilin FKBP genes and expression patterns in Zea mays. Genet. Mol. Res. 11:1690-1700. http://dx.doi.org/10.4238/2012.June.25.2.
64. Kang CB, Feng L, Chia J, Yoon HS. 2005. Molecular characterization of FK-506 binding protein 38 and its potential regulatory role on the antiapoptotic protein Bcl-2. Biochem. Biophys. Res. Commun. 337:30-38. http://dx.doi.org/10.1016/j.bbrc.2005.09.023.
65. Wang L. 2011. FKBP51 regulation of AKT/protein kinase B phosphorylation. Curr. Opin. Pharmacol. 11:360-364. http://dx.doi.org/10.1016/j.coph.2011.03.008.
66. Kang CB, Hong Y, Dhe-Paganon S, Yoon HS. 2008. FKBP family proteins: immunophilins with versatile biological functions. Neurosignals 16:318-325. http://dx.doi.org/10.1159/000123041.
67. Wang P, Heitman J. 2005. The cyclophilins. Genome Biol. 6:226. http://dx.doi.org/10.1186/gb-2005-6-7-226.
68. Heikkinen O, Seppala R, Tossavainen H, Heikkinen S, Koskela H, Permi P, Kilpeläinen I. 2009. Solution structure of the parvulin-type PPIase domain of Staphylococcus aureus PrsA - implications for the catalytic mechanism of parvulins. BMC Struct. Biol. 9:17. http://dx.doi.org/10.1186/1472-6807-9-17.
69. Bang H, Pecht A, Raddatz G, Scior T, Solbach W, Brune K, Pahl A. 2000. Prolyl isomerases in a minimal cell. Catalysis of protein folding by trigger factor from Mycoplasma genitalium. Eur. J. Biochem. 267:3270-3280. http://dx.doi.org/10.1046/j.1432-1327.2000.01355.x.
70. Lakshmipathy SK, Gupta R, Pinkert S, Etchells SA, Hartl FU. 2010. Versatility of trigger factor interactions with ribosome-nascent chain complexes. J. Biol. Chem. 285:27911-27923. http://dx.doi.org/10.1074/jbc.M110.134163.
71. Lakshmipathy SK, Tomic S, Kaiser CM, Chang H-C, Genevaux P, Georgopoulos C, Barral JM, Johnson AE, Hartl FU, Etchells SA. 2007. Identification of nascent chain interaction sites on trigger factor. J. Biol. Chem. 282:12186-12193. http://dx.doi.org/10.1074/jbc.M609871200.
72. Arié JP, Sassoon N, Betton JM. 2001. Chaperone function of FkpA, a heat shock prolyl isomerase, in the periplasm of Escherichia coli. Mol. Microbiol. 39:199-210. http://dx.doi.org/10.1046/j.1365-2958.2001.02250.x.
73. Ramm K, Plückthun A. 2001. High enzymatic activity and chaperone function are mechanistically related features of the dimeric E. coli peptidyl-prolyl-isomerase FkpA. J. Mol. Biol. 310:485-498. http://dx.doi.org/10.1006/jmbi.2001.4747.
74. Hullmann J, Patzer SI, Römer C, Hantke K, Braun V. 2008. Periplasmic chaperone FkpA is essential for imported colicin M toxicity. Mol. Microbiol. 69: 926-937. http://dx.doi.org/10.1111/j.1365-2958.2008.06327.x.
75. Rahfeld JU, Rücknagel KP, Stoller G, Horne SM, Schierhorn A, Young KD, Fischer G. 1996. Isolation and amino acid sequence of a new 22-kDa FKBP-like peptidyl-prolyl cis/trans-isomerase of Escherichia coli. Similarity to Mip-like proteins of pathogenic bacteria. J. Biol. Chem. 271:22130-22138.
76. Bernhardt TG, Roof WD, Young R. 2002. The Escherichia coli FKBP-type PPIase SlyD is required for the stabilization of the E lysis protein of bacteriophage φX174. Mol. Microbiol. 45:99-108. http://dx.doi.org/10.1046/j.1365-2958.2002.02984.x.
77. Zhang JW, Butland G, Greenblatt JF, Emili A, Zamble DB. 2005. A role for SlyD in the Escherichia coli hydrogenase biosynthetic pathway. J. Biol. Chem. 280:4360-4366. http://dx.doi.org/10.1074/jbc.M411799200.
78. Zhang JW, Leach MR, Zamble DB. 2007. The peptidyl-prolyl isomerase activity of SlyD is not required for maturation of Escherichia coli hydrogenase. J. Bacteriol. 189:7942-7944. http://dx.doi.org/10.1128/JB.00922-07.
79. Cheng T, Li H, Xia W, Sun H. 2012. Multifaceted SlyD from Helicobacter pylori: implication in [NiFe] hydrogenase maturation. J. Biol. Inorg. Chem. 17:331-343. http://dx.doi.org/10.1007/s00775-011-0855-y.
80. Mukouhara T, Arimoto T, Cho K, Yamamoto M, Igarashi T. 2011. Surface lipoprotein PpiA of Streptococcus mutans suppresses scavenger receptor MARCO-dependent phagocytosis by macrophages. Infect. Immun. 79:4933-4940. http://dx.doi.org/10.1128/IAI.05693-11.
81. Herrler M, Bang H, Marahiel MA. 1994. Cloning and characterization of ppiB, a Bacillus subtilis gene which encodes a cyclosporin A-sensitive peptidyl-prolyl cis-trans isomerase. Mol. Microbiol. 11:1073-1083. http://dx.doi.org/10.1111/j.1365-2958.1994.tb00384.x.
82. Graumann P, Schröder K, Schmid R, Marahiel MA. 1996. Cold shock stress-induced proteins in Bacillus subtilis. J. Bacteriol. 178:4611-4619.
83. Behrens-Kneip S. 2010. The role of SurA factor in outer membrane protein transport and virulence. Int. J. Med. Microbiol. 300:421-428. http://dx.doi.org/10.1016/j.ijmm.2010.04.012.
84. Weininger U, Jakob RP, Kovermann M, Balbach J, Schmid FX. 2010. The prolyl isomerase domain of PpiD from Escherichia coli shows a parvulin fold but is devoid of catalytic activity. Protein Sci. 19:6-18. http://dx.doi.org/10.1002/pro.277.
85. Matern Y, Barion B, Behrens-Kneip S. 2010. PpiD is a player in the network of periplasmic chaperones in Escherichia coli. BMC Microbiol. 10:251. http://dx.doi.org/10.1186/1471-2180-10-251.
86. Ge X, Lyu Z-X, Liu Y, Wang R, Zhao XS, Fu X, Chang Z. 2014. Identification of FkpA as a key quality control factor for the biogenesis of outer membrane proteins under heat shock conditions. J. Bacteriol. 196:672-680. http://dx.doi.org/10.1128/JB.01069-13.
87. Vitikainen M, Lappalainen I, Seppala R, Antelmann H, Boer H, Taira S, Savilahti H, Hecker M, Vihinen M, Sarvas M, Kontinen VP. 2004. Structure-function analysis of PrsA reveals roles for the parvulin-like and flanking N- and C-terminal domains in protein folding and secretion in Bacillus subtilis. J. Biol. Chem. 279:19302-19314. http://dx.doi.org/10.1074/jbc.M400861200.
88. Wahlström E, Vitikainen M, Kontinen VP, Sarvas M. 2003. The extracytoplasmic folding factor PrsA is required for protein secretion only in the presence of the cell wall in Bacillus subtilis. Microbiology 149:569-577. http://dx.doi.org/10.1099/mic.0.25511-0.
89. Drouault S, Anba J, Bonneau S, Bolotin A, Ehrlich SD, Renault P. 2002. The peptidyl-prolyl isomerase motif is lacking in PmpA, the PrsA-like protein involved in the secretion machinery of Lactococcus lactis. Appl. Environ. Microbiol. 68:3932-3942. http://dx.doi.org/10.1128/AEM.68.8.3932-3942.2002.
90. Milohanic E, Glaser P, Coppée J-Y, Frangeul L, Vega Y, Vázquez-Boland JA, Kunst F, Cossart P, Buchrieser C. 2003. Transcriptome analysis of Listeria monocytogenes identifies three groups of genes differently regulated by PrfA. Mol. Microbiol. 47:1613-1625. http://dx.doi.org/10.1046/j.1365-2958.2003.03413.x.
91. Hyyryläinen H-L, Marciniak BC, Dahncke K, Pietiäinen M, Courtin P, Vitikainen M, Seppala R, Otto A, Becher D, Chapot-Chartier M-P, Kuipers OP, Kontinen VP. 2010. Penicillin-binding protein folding is dependent on the PrsA peptidyl-prolyl cis-trans isomerase in Bacillus subtilis. Mol. Microbiol. 77:108-127. http://dx.doi.org/10.1111/j.1365-2958.2010.07188.x.
92. Nickell SP, Scheibel LW, Cole GA. 1982. Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro. Infect. Immun. 37:1093-1100.
93. Bell A, Wernli B, Franklin RM. 1994. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. Biochem. Pharmacol. 48:495-503. http://dx.doi.org/10.1016/0006-2952(94)90279-8.
94. Perkins ME, Wu TW, Le Blancq SM. 1998. Cyclosporin analogs inhibit in vitro growth of Cryptosporidium parvum. Antimicrob. Agents Chemother. 42:843-848.
95. High KP, Joiner KA, Handschumacher RE. 1994. Isolation, cDNA sequences, and biochemical characterization of the major cyclosporin-binding proteins of Toxoplasma gondii. J. Biol. Chem. 269:9105-9112.
96. Reddy GR. 1995. Cloning and characterization of a Plasmodium falciparum cyclophilin gene that is stage-specifically expressed. Mol. Biochem. Parasitol. 73:111-121. http://dx.doi.org/10.1016/0166-6851(95)00103-8.
97. Hirtzlin J, Färber PM, Franklin RM, Bell A. 1995. Molecular and biochemical characterization of a Plasmodium falciparum cyclophilin containing a cleavable signal sequence. Eur. J. Biochem. 232:765-772. http://dx.doi.org/10.1111/j.1432-1033.1995.tb20871.x.
98. Marín-Menéndez A, Bell A. 2011. Overexpression, purification and assessment of cyclosporin binding of a family of cyclophilins and cyclophilin-like proteins of the human malarial parasite Plasmodium falciparum. Protein Expr. Purif. 78:225-234. http://dx.doi.org/10.1016/j.pep.2011.04.012.
99. Marín-Menéndez A, Monaghan P, Bell A. 2012. A family of cyclophilinlike molecular chaperones in Plasmodium falciparum. Mol. Biochem. Parasitol. 184:44-47. http://dx.doi.org/10.1016/j.molbiopara.2012.04.006.
100. Aliberti J, Valenzuela JG, Carruthers VB, Hieny S, Andersen J, Charest H, Reis e Sousa C, Fairlamb A, Ribeiro JM, Sher A. 2003. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat. Immunol. 4:485-490. http://dx.doi.org/10.1038/ni915.
101. Yarovinsky F, Andersen JF, King LR, Caspar P, Aliberti J, Golding H, Sher A. 2004. Structural determinants of the anti-HIV activity of a CCR5 antagonist derived from Toxoplasma gondii. J. Biol. Chem. 279:53635-53642. http://dx.doi.org/10.1074/jbc.M410550200.
102. Del Rio L, Butcher BA, Bennouna S, Hieny S, Sher A, Denkers EY. 2004. Toxoplasma gondii triggers myeloid differentiation factor 88-dependent IL-12 and chemokine ligand 2 (monocyte chemoattractant protein 1) responses using distinct parasite molecules and host receptors. J. Immunol. 172:6954-6960. http://dx.doi.org/10.4049/jimmunol.172.11.6954.
103. Tuo W, Fetterer R, Jenkins M, Dubey JP. 2005. Identification and characterization of Neospora caninum cyclophilin that elicits gamma interferon production. Infect. Immun. 73:5093-5100. http://dx.doi.org/10.1128/IAI.73.8.5093-5100.2005.
104. Sheiner L, Vaidya AB, McFadden GI. 2013. The metabolic roles of the endosymbiotic organelles of Toxoplasma and Plasmodium spp. Curr. Opin. Microbiol. 16:452-458. http://dx.doi.org/10.1016/j.mib.2013.07.003.
105. Potenza M, Galat A, Minning TA, Ruiz AM, Duran R, Tarleton RL, Marín M, Fichera LE, Búa J. 2006. Analysis of the Trypanosoma cruzi cyclophilin gene family and identification of cyclosporin A binding proteins. Parasitology 132:867-882. http://dx.doi.org/10.1017/S0031182005009558.
106. Dao-Thi MH, Transue TR, Pellé R, Murphy NB, Poortmans F, Steyaert J. 1998. Expression, purification, crystallization and preliminary X-ray analysis of cyclophilin A from the bovine parasite Trypanosoma brucei brucei. Acta Crystallogr. D Biol. Crystallogr. 54:1046-1048. http://dx.doi.org/10.1107/S0907444998001607.
107. Búa J, Aslund L, Pereyra N, García GA, Bontempi EJ, Ruiz AM. 2001. Characterisation of a cyclophilin isoform in Trypanosoma cruzi. FEMS Microbiol. Lett. 200:43-47. http://dx.doi.org/10.1111/j.1574-6968.2001.tb10690.x.
108. Pellé R, McOdimba F, Chuma F, Wasawo D, Pearson TW, Murphy NB. 2002. The African trypanosome cyclophilin A homologue contains unusual conserved central and N-terminal domains and is developmentally regulated. Gene 290:181-191. http://dx.doi.org/10.1016/S0378-1119(02)00559-0.
109. Rascher C, Pahl A, Pecht A, Brune K, Solbach W, Bang H. 1998. Leishmania major parasites express cyclophilin isoforms with an unusual interaction with calcineurin. Biochem. J. 334:659-667.
110. Hoerauf A, Rascher C, Bang R, Pahl A, Solbach W, Brune K, Röllinghoff M, Bang H. 1997. Host-cell cyclophilin is important for the intracellular replication of Leishmania major. Mol. Microbiol. 24:421-429. http://dx.doi.org/10.1046/j.1365-2958.1997.3401716.x.
111. Dutta M, Delhi P, Sinha KM, Banerjee R, Datta AK. 2001. Lack of abundance of cytoplasmic cyclosporin A-binding protein renders free-living Leishmania donovani resistant to cyclosporin A. J. Biol. Chem. 276:19294-19300. http://dx.doi.org/10.1074/jbc.M009379200.
112. Chakraborty A, Das I, Datta R, Sen B, Bhattacharyya D, Mandal C, Datta AK. 2002. A single-domain cyclophilin from Leishmania donovani reactivates soluble aggregates of adenosine kinase by isomerase-independent chaperone function. J. Biol. Chem. 277:47451-47460. http://dx.doi.org/10.1074/jbc.M204827200.
113. Sen B, Chakraborty A, Datta R, Bhattacharyya D, Datta AK. 2006. Reversal of ADP-mediated aggregation of adenosine kinase by cyclophilin leads to its reactivation. Biochemistry (Mosc.) 45:263-271. http://dx.doi.org/10.1021/bi0518489.
114. Chakraborty A, Sen B, Datta R, Datta AK. 2004. Isomerase-independent chaperone function of cyclophilin ensures aggregation prevention of adenosine kinase both in vitro and under in vivo conditions. Biochemistry (Mosc.) 43:11862-11872. http://dx.doi.org/10.1021/bi049490o.
115. Ostoa-Saloma P, César Carrero J, Petrossian P, Hérión P, Landa A, Pedro Laclette J. 2000. Cloning, characterization and functional expression of a cyclophilin of Entamoeba histolytica. Mol. Biochem. Parasitol. 107:219-225. http://dx.doi.org/10.1016/S0166-6851(00)00190-0.
116. Akbar MA, Chatterjee NS, Sen P, Debnath A, Pal A, Bera T, Das P. 2004. Genes induced by a high-oxygen environment in Entamoeba histolytica. Mol. Biochem. Parasitol. 133:187-196. http://dx.doi.org/10.1016/j.molbiopara.2003.10.006.
117. Monaghan P, Bell A. 2005. A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl-prolyl cis-trans isomerase and chaperone activities. Mol. Biochem. Parasitol. 139:185-195. http://dx.doi.org/10.1016/j.molbiopara.2004.10.007.
118. Kumar R, Adams B, Musiyenko A, Shulyayeva O, Barik S. 2005. The FK506-binding protein of the malaria parasite, Plasmodium falciparum, is a FK506-sensitive chaperone with FK506-independent calcineurin-inhibitory activity. Mol. Biochem. Parasitol. 141:163-173. http://dx.doi.org/10.1016/j.molbiopara.2005.02.007.
119. Alag R, Shin J, Yoon HS. 2009. NMR assignments of the FK506-binding domain of FK506-binding protein 35 from Plasmodium vivax. Biomol. NMR Assign. 3:243-245. http://dx.doi.org/10.1007/s12104-009-9185-1.
120. Rajan S, Austin D, Harikishore A, Nguyen QT, Baek K, Yoon HS. 2014. Crystal structure of Plasmodium vivax FK506-binding protein 25 reveals conformational changes responsible for its noncanonical activity. Proteins 82:1235-1244. http://dx.doi.org/10.1002/prot.24487.
121. Brydges SD, Sherman GD, Nockemann S, Loyens A, Däubener W, Dubremetz JF, Carruthers VB. 2000. Molecular characterization of TgMIC5, a proteolytically processed antigen secreted from the micronemes of Toxoplasma gondii. Mol. Biochem. Parasitol. 111:51-66. http://dx.doi.org/10.1016/S0166-6851(00)00296-6.
122. Brydges SD, Zhou XW, Huynh M-H, Harper JM, Mital J, Adjogble KDZ, Däubener W, Ward GE, Carruthers VB. 2006. Targeted deletion of MIC5 enhances trimming proteolysis of Toxoplasma invasion proteins. Eukaryot. Cell 5:2174-2183. http://dx.doi.org/10.1128/EC.00163-06.
123. Saouros S, Dou Z, Henry M, Marchant J, Carruthers VB, Matthews S. 2012. Microneme protein 5 regulates the activity of Toxoplasma subtilisin 1 by mimicking a subtilisin prodomain. J. Biol. Chem. 287:36029-36040. http://dx.doi.org/10.1074/jbc.M112.389825.
124. Erben ED, Daum S, Téllez-Iñón MT. 2007. The Trypanosoma cruzi PIN1 gene encodes a parvulin peptidyl-prolyl cis/trans isomerase able to replace the essential ESS1 in Saccharomyces cerevisiae. Mol. Biochem. Parasitol. 153:186-193. http://dx.doi.org/10.1016/j.molbiopara.2007.03.004.
125. Erben ED, Valguarnera E, Nardelli S, Chung J, Daum S, Potenza M, Schenkman S, Téllez-Iñón MT. 2010. Identification of an atypical peptidyl-prolyl cis/trans isomerase from trypanosomatids. Biochim. Biophys. Acta 1803:1028-1037. http://dx.doi.org/10.1016/j.bbamcr.2010.05.006.
126. Erben ED, Nardelli SC, de Jesus TCL, Schenkman S, Tellez-Iñon MT. 2013. Trypanosomatid pin1-type peptidyl-prolyl isomerase is cytosolic and not essential for cell proliferation. J. Eukaryot. Microbiol. 60:101-105. http://dx.doi.org/10.1111/jeu.12009.
127. Goh JY, Lai C-Y, Tan LC, Yang D, He CY, Liou Y-C. 2010. Functional characterization of two novel parvulins in Trypanosoma brucei. FEBS Lett. 584:2901-2908. http://dx.doi.org/10.1016/j.febslet.2010.04.077.
128. Sun L, Wu X, Peng Y, Goh JY, Liou Y-C, Lin D, Zhao Y. 2012. Solution structural analysis of the single-domain parvulin TbPin1. PLoS One 7:e43017. http://dx.doi.org/10.1371/journal.pone.0043017.
129. Hermans PWM, Adrian PV, Albert C, Estevão S, Hoogenboezem T, Luijendijk IHT, Kamphausen T, Hammerschmidt S. 2006. The streptococcal lipoprotein rotamase A (SlrA) is a functional peptidyl-prolyl isomerase involved in pneumococcal colonization. J. Biol. Chem. 281:968-976. http://dx.doi.org/10.1074/jbc.M510014200.
130. Purdy GE, Fisher CR, Payne SM. 2007. IcsA surface presentation in Shigella flexneri requires the periplasmic chaperones DegP, Skp, and SurA. J. Bacteriol. 189:5566-5573. http://dx.doi.org/10.1128/JB.00483-07.
131. Alonzo F, III, Freitag NE. 2010. Listeria monocytogenes PrsA2 is required for virulence factor secretion and bacterial viability within the host cell cytosol. Infect. Immun. 78:4944-4957. http://dx.doi.org/10.1128/IAI.00532-10.
132. Forster BM, Zemansky J, Portnoy DA, Marquis H. 2011. Posttranslocation chaperone PrsA2 regulates the maturation and secretion of Listeria monocytogenes proprotein virulence factors. J. Bacteriol. 193:5961-5970. http://dx.doi.org/10.1128/JB.05307-11.
133. Justice SS, Lauer SR, Hultgren SJ, Hunstad DA. 2006. Maturation of intracellular Escherichia coli communities requires SurA. Infect. Immun. 74:4793-4800. http://dx.doi.org/10.1128/IAI.00355-06.
134. Vertommen D, Ruiz N, Leverrier P, Silhavy TJ, Collet J-F. 2009. Characterization of the role of the Escherichia coli periplasmic chaperone SurA using differential proteomics. Proteomics 9:2432-2443. http://dx.doi.org/10.1002/pmic.200800794.
135. Confer AW, Ayalew S. 2013. The OmpA family of proteins: roles in bacterial pathogenesis and immunity. Vet. Microbiol. 163(3-4):207-222. http://dx.doi.org/10.1016/j.vetmic.2012.08.019.
136. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. 2003. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301:105-107. http://dx.doi.org/10.1126/science.1084550.
137. Remaut H, Tang C, Henderson NS, Pinkner JS, Wang T, Hultgren SJ, Thanassi DG, Waksman G, Li H. 2008. Fiber formation across the bacterial outer membrane by the chaperone/usher pathway. Cell 133:640-652. http://dx.doi.org/10.1016/j.cell.2008.03.033.
138. Palomino C, Marín E, Fernández LÁ. 2011. The fimbrial usher FimD follows the SurA-BamB pathway for its assembly in the outer membrane of Escherichia coli. J. Bacteriol. 193:5222-5230. http://dx.doi.org/10.1128/JB.05585-11.
139. Bodelón G, Marín E, Fernández LA. 2009. Role of periplasmic chaperones and BamA (YaeT/Omp85) in folding and secretion of intimin from enteropathogenic Escherichia coli strains. J. Bacteriol. 191:5169-5179. http://dx.doi.org/10.1128/JB.00458-09.
140. Watts KM, Hunstad DA. 2008. Components of SurA required for outer membrane biogenesis in uropathogenic Escherichia coli. PLoS One 3:e3359. http://dx.doi.org/10.1371/journal.pone.0003359.
141. Obi IR, Francis MS. 2013. Demarcating SurA activities required for outer membrane targeting of Yersinia pseudotuberculosis adhesins. Infect. Immun. 81:2296-2308. http://dx.doi.org/10.1128/IAI.01208-12.
142. Fardini Y, Trotereau J, Bottreau E, Souchard C, Velge P, Virlogeux-Payant I. 2009. Investigation of the role of the BAM complex and SurA chaperone in outer-membrane protein biogenesis and type III secretion system expression in Salmonella. Microbiology 155:1613-1622. http://dx.doi.org/10.1099/mic.0.025155-0.
143. Mansfield J, Genin S, Magori S, Citovsky V, Sriariyanum M, Ronald P, Dow M, Verdier V, Beer SV, Machado MA, Toth I, Salmond G, Foster GD. 2012. Top 10 plant pathogenic bacteria in molecular plant pathology. Mol. Plant Pathol. 13:614-629. http://dx.doi.org/10.1111/j.1364-3703.2012.00804.x.
144. Rondelet A, Condemine G. 2012. SurA is involved in the targeting to the outer membrane of a Tat signal sequence-anchored protein. J. Bacteriol. 194:6131-6142. http://dx.doi.org/10.1128/JB.01419-12.
145. Basak C, Pathak SK, Bhattacharyya A, Pathak S, Basu J, Kundu M. 2005. The secreted peptidyl prolyl cis/trans-isomerase HP0175 of Helicobacter pylori induces apoptosis of gastric epithelial cells in a TLR4- and apoptosis signal-regulating kinase 1-dependent manner. J. Immunol. 174:5672-5680. http://dx.doi.org/10.4049/jimmunol.174.9.5672.
146. Hodak H, Wohlkönig A, Smet-Nocca C, Drobecq H, Wieruszeski J-M, Sénéchal M, Landrieu I, Locht C, Jamin M, Jacob-Dubuisson F. 2008. The peptidyl-prolyl isomerase and chaperone Par27 of Bordetella pertussis as the prototype for a new group of parvulins. J. Mol. Biol. 376:414-426. http://dx.doi.org/10.1016/j.jmb.2007.10.088.
147. Clantin B, Leyrat C, Wohlkönig A, Hodak H, Ribeiro Ede A, Jr., Martinez N, Baud C, Smet-Nocca C, Villeret V, Jacob-Dubuisson F, Jamin M. 2010. Structure and plasticity of the peptidyl-prolyl isomerase Par27 of Bordetella pertussis revealed by X-ray diffraction and small-angle X-ray scattering. J. Struct. Biol. 169:253-265. http://dx.doi.org/10.1016/j.jsb.2009.11.007.
148. Kale A, Phansopa C, Suwannachart C, Craven CJ, Rafferty JB, Kelly DJ. 2011. The virulence factor PEB4 (Cj0596) and the periplasmic protein Cj1289 are two structurally related SurA-like chaperones in the human pathogen Campylobacter jejuni. J. Biol. Chem. 286:21254-21265. http://dx.doi.org/10.1074/jbc.M111.220442.
149. Alonzo F, III, Port GC, Cao M, Freitag NE. 2009. The posttranslocation chaperone PrsA2 contributes to multiple facets of Listeria monocytogenes pathogenesis. Infect. Immun. 77:2612-2623. http://dx.doi.org/10.1128/IAI.00280-09.
150. Zemansky J, Kline BC, Woodward JJ, Leber JH, Marquis H, Portnoy DA. 2009. Development of a mariner-based transposon and identification of Listeria monocytogenes determinants, including the peptidylprolyl isomerase PrsA2, that contribute to its hemolytic phenotype. J. Bacteriol. 191:3950-3964. http://dx.doi.org/10.1128/JB.00016-09.
151. Alonzo F, III, Xayarath B, Whisstock JC, Freitag NE. 2011. Functional analysis of the Listeria monocytogenes secretion chaperone PrsA2 and its multiple contributions to bacterial virulence. Mol. Microbiol. 80:1530-1548. http://dx.doi.org/10.1111/j.1365-2958.2011.07665.x.
152. Overweg K, Kerr A, Sluijter M, Jackson MH, Mitchell TJ, de Jong AP, de Groot R, Hermans PW. 2000. The putative proteinase maturation proteinAof Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses. Infect. Immun. 68:4180-4188. http://dx.doi.org/10.1128/IAI.68.7.4180-4188.2000.
153. Adrian PV, Bogaert D, Oprins M, Rapola S, Lahdenkari M, Kilpi T, de Groot R, Käyhty H, Hermans PWM. 2004. Development of antibodies against pneumococcal proteins alpha-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and otitis media. Vaccine 22:2737-2742. http://dx.doi.org/10.1016/j.vaccine.2004.01.042.
154. Cron LE, Bootsma HJ, Noske N, Burghout P, Hammerschmidt S, Hermans PWM. 2009. Surface-associated lipoprotein PpmA of Streptococcus pneumoniae is involved in colonization in a strain-specific manner. Microbiology 155:2401-2410. http://dx.doi.org/10.1099/mic.0.026765-0.
155. Wen ZT, Suntharaligham P, Cvitkovitch DG, Burne RA. 2005. Trigger factor in Streptococcus mutans is involved in stress tolerance, competence development, and biofilm formation. Infect. Immun. 73:219-225. http://dx.doi.org/10.1128/IAI.73.1.219-225.2005.
156. Lyon WR, Gibson CM, Caparon MG. 1998. A role for trigger factor and an Rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes. EMBO J. 17:6263-6275. http://dx.doi.org/10.1093/emboj/17.21.6263.
157. Lyon WR, Caparon MG. 2003. Trigger factor-mediated prolyl isomerization influences maturation of the Streptococcus pyogenes cysteine protease. J. Bacteriol. 185:3661-3667. http://dx.doi.org/10.1128/JB.185.12.3661-3667.2003.
158. Wu T, Zhao Z, Zhang L, Ma H, Lu K, Ren W, Liu Z, Chang H, Bei W, Qiu Y, Chen H. 2011. Trigger factor of Streptococcus suis is involved in stress tolerance and virulence. Microb. Pathog. 51:69-76. http://dx.doi.org/10.1016/j.micpath.2010.10.001.
159. Bigot A, Botton E, Dubail I, Charbit A. 2006. A homolog of Bacillus subtilis trigger factor in Listeria monocytogenes is involved in stress tolerance and bacterial virulence. Appl. Environ. Microbiol. 72:6623-6631. http://dx.doi.org/10.1128/AEM.00624-06.
160. Yau W-L, Blisnick T, Taly J-F, Helmer-Citterich M, Schiene-Fischer C, Leclercq O, Li J, Schmidt-Arras D, Morales MA, Notredame C, Romo D, Bastin P, Späth GF. 2010. Cyclosporin A treatment of Leishmania donovani reveals stage-specific functions of cyclophilins in parasite proliferation and viability. PLoS Negl. Trop. Dis. 4:e729. http://dx.doi.org/10.1371/journal.pntd.0000729.
161. Ibrahim HM, Bannai H, Xuan X, Nishikawa Y. 2009. Toxoplasma gondii cyclophilin 18-mediated production of nitric oxide induces bradyzoite conversion in a CCR5-dependent manner. Infect. Immun. 77: 3686-3695. http://dx.doi.org/10.1128/IAI.00361-09.
162. Ibrahim HM, Xuan X, Nishikawa Y. 2010. Toxoplasma gondii cyclophilin 18 regulates the proliferation and migration of murine macrophages and spleen cells. Clin. Vaccine Immunol. 17:1322-1329. http://dx.doi.org/10.1128/CVI.00128-10.
163. Kulkarni MM, Karafova A, Kamysz W, Schenkman S, Pelle R, McGwire BS. 2013. Secreted trypanosome cyclophilin inactivates lytic insect defense peptides and induces parasite calcineurin activation and infectivity. J. Biol. Chem. 288: 8772-8784. http://dx.doi.org/10.1074/jbc.M112.421057.
164. Sherry B, Zybarth G, Alfano M, Dubrovsky L, Mitchell R, Rich D, Ulrich P, Bucala R, Cerami A, Bukrinsky M. 1998. Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 95:1758-1763. http://dx.doi.org/10.1073/pnas.95.4.1758.
165. Allain F, Vanpouille C, Carpentier M, Slomianny M-C, Durieux S, Spik G. 2002. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Proc. Natl. Acad. Sci. U. S. A. 99: 2714-2719. http://dx.doi.org/10.1073/pnas.052284899.
166. Yurchenko V, O'Connor M, Dai WW, Guo H, Toole B, Sherry B, Bukrinsky M. 2001. CD147 is a signaling receptor for cyclophilin B. Biochem. Biophys. Res. Commun. 288:786-788. http://dx.doi.org/10.1006/bbrc.2001.5847.
167. Yurchenko V, Zybarth G, O'Connor M, Dai WW, Franchin G, Hao T, Guo H, Hung H-C, Toole B, Gallay P, Sherry B, Bukrinsky M. 2002. Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J. Biol. Chem. 277:22959-22965. http://dx.doi.org/10.1074/jbc.M201593200.
168. Yurchenko V, Xue Z, Sherry B, Bukrinsky M. 2008. Functional analysis of Leishmania major cyclophilin. Int. J. Parasitol. 38:633-639. http://dx.doi.org/10.1016/j.ijpara.2007.10.001.
169. Luban J, Bossolt KL, Franke EK, Kalpana GV, Goff SP. 1993. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73:1067-1078. http://dx.doi.org/10.1016/0092-8674(93)90637-6.
170. Bose S, Mathur M, Bates P, Joshi N, Banerjee AK. 2003. Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype. J. Gen. Virol. 84:1687-1699. http://dx.doi.org/10.1099/vir.0.19074-0.
171. Watashi K, Ishii N, Hijikata M, Inoue D, Murata T, Miyanari Y, Shimotohno K. 2005. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol. Cell 19:111-122. http://dx.doi.org/10.1016/j.molcel.2005.05.014.
172. Liu X, Sun L, Yu M, Wang Z, Xu C, Xue Q, Zhang K, Ye X, Kitamura Y, Liu W. 2009. Cyclophilin A interacts with influenza A virus M1 protein and impairs the early stage of the viral replication. Cell. Microbiol. 11:730-741. http://dx.doi.org/10.1111/j.1462-5822.2009.01286.x.
173. Kambara H, Tani H, Mori Y, Abe T, Katoh H, Fukuhara T, Taguwa S, Moriishi K, Matsuura Y. 2011. Involvement of cyclophilin B in the replication of Japanese encephalitis virus. Virology 412:211-219. http://dx.doi.org/10.1016/j.virol.2011.01.011.
174. Pfefferle S, Schöpf J, Kögl M, Friedel CC, Müller MA, Carbajo-Lozoya J, Stellberger T, von Dall'Armi E, Herzog P, Kallies S, Niemeyer D, Ditt V, Kuri T, Züst R, Pumpor K, Hilgenfeld R, Schwarz F, Zimmer R, Steffen I, Weber F, Thiel V, Herrler G, Thiel H-J, Schwegmann-Wessels C, Pöhlmann S, Haas J, Drosten C, von Brunn A. 2011. The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog. 7:e1002331. http://dx.doi.org/10.1371/journal.ppat.1002331.
175. Keyes LR, Bego MG, Soland M, St Jeor S. 2012. Cyclophilin A is required for efficient human cytomegalovirus DNA replication and reactivation. J. Gen. Virol. 93:722-732. http://dx.doi.org/10.1099/vir.0.037309-0.
176. He H, Mou Z, Li W, Fei L, Tang Y, Zhang J, Yan P, Chen Z, Yang X, Shen Z, Li J, Wu Y. 2013. Proteomic methods reveal cyclophilin A function as a host restriction factor against rotavirus infection. Proteomics 13:1121-1132. http://dx.doi.org/10.1002/pmic.201100579.
177. Frausto SD, Lee E, Tang H. 2013. Cyclophilins as modulators of viral replication. Viruses 5:1684-1701. http://dx.doi.org/10.3390/v5071684.
178. Liu X, Zhao Z, Liu W. 2013. Insights into the roles of cyclophilin A during influenza virus infection. Viruses 5:182-191. http://dx.doi.org/10.3390/v5010182.
179. Endrich MM, Gehrig P, Gehring H. 1999. Maturation-induced conformational changes of HIV-1 capsid protein and identification of two high affinity sites for cyclophilins in the C-terminal domain. J. Biol. Chem. 274:5326-5332. http://dx.doi.org/10.1074/jbc.274.9.5326.
180. Kootstra NA, Munk C, Tonnu N, Landau NR, Verma IM. 2003. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc. Natl. Acad. Sci. U. S. A. 100:1298-1303. http://dx.doi.org/10.1073/pnas.0337541100.
181. Towers GJ, Hatziioannou T, Cowan S, Goff SP, Luban J, Bieniasz PD. 2003. CyclophilinAmodulates the sensitivity of HIV-1 to host restriction factors. Nat. Med. 9:1138-1143. http://dx.doi.org/10.1038/nm910.
182. Ikeda Y, Ylinen LMJ, Kahar-Bador M, Towers GJ. 2004. Influence of gag on human immunodeficiency virus type 1 species-specific tropism. J. Virol. 78:11816-11822. http://dx.doi.org/10.1128/JVI.78.21.11816-11822.2004.
183. Bon Homme M, Carter C, Scarlata S. 2005. The cysteine residues of HIV-1 capsid regulate oligomerization and cyclophilin A-induced changes. Biophys. J. 88:2078-2088. http://dx.doi.org/10.1529/biophysj.104.053298.
184. Thai V, Renesto P, Fowler CA, Brown DJ, Davis T, Gu W, Pollock DD, Kern D, Raoult D, Eisenmesser EZ. 2008. Structural, biochemical, and in vivo characterization of the first virally encoded cyclophilin from the mimivirus. J. Mol. Biol. 378:71-86. http://dx.doi.org/10.1016/j.jmb.2007.08.051.
185. Manganaro L, Lusic M, Gutierrez MI, Cereseto A, Del Sal G, Giacca M. 2010. Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes. Nat. Med. 16:329-333. http://dx.doi.org/10.1038/nm.2102.
186. Narita Y, Murata T, Ryo A, Kawashima D, Sugimoto A, Kanda T, Kimura H, Tsurumi T. 2013. Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication. J. Virol. 87:2120-2127. http://dx.doi.org/10.1128/JVI.02634-12.
187. Deng W, Chen L, Wood DW, Metcalfe T, Liang X, Gordon MP, Comai L, Nester EW. 1998. Agrobacterium VirD2 protein interacts with plant host cyclophilins. Proc. Natl. Acad. Sci. U. S. A. 95:7040-7045. http://dx.doi.org/10.1073/pnas.95.12.7040.
188. Coaker G, Falick A, Staskawicz B. 2005. Activation of a phytopathogenic bacterial effector protein by a eukaryotic cyclophilin. Science 308:548-550. http://dx.doi.org/10.1126/science.1108633.
189. Axtell MJ, Staskawicz BJ. 2003. Initiation of RPS2-specified disease resistance in Arabidopsis is coupled to the AvrRpt2-directed elimination of RIN4. Cell 112:369-377. http://dx.doi.org/10.1016/S0092-8674(03)00036-9.
190. Mackey D, Belkhadir Y, Alonso JM, Ecker JR, Dangl JL. 2003. Arabidopsis RIN4 is a target of the type III virulence effector AvrRpt2 and modulates RPS2-mediated resistance. Cell 112:379-389. http://dx.doi.org/10.1016/S0092-8674(03)00040-0.
191. Coaker G, Zhu G, Ding Z, Van Doren SR, Staskawicz B. 2006. Eukaryotic cyclophilin as a molecular switch for effector activation. Mol. Microbiol. 61:1485-1496. http://dx.doi.org/10.1111/j.1365-2958.2006.05335.x.
192. Aumüller T, Jahreis G, Fischer G, Schiene-Fischer C. 2010. Role of prolyl cis/trans isomers in cyclophilin-assisted Pseudomonas syringae AvrRpt2 protease activation. Biochemistry (Mosc.) 49:1042-1052. http://dx.doi.org/10.1021/bi901813e.
193. Zhu C, Wang Y, Li Y, Bhatti KH, Tian Y, Wu J. 2011. Overexpression of a cotton cyclophilin gene (GhCyp1) in transgenic tobacco plants confers dual tolerance to salt stress and Pseudomonas syringae pv. tabaci infection. Plant Physiol. Biochem. 49:1264-1271. http://dx.doi.org/10.1016/j.plaphy.2011.09.001.
194. Pogorelko GV, Mokryakova M, Fursova OV, Abdeeva I, Piruzian ES, Bruskin SA. 2014. Characterization of three Arabidopsis thaliana immunophilin genes involved in the plant defense response against Pseudomonas syringae. Gene 538:12-22. http://dx.doi.org/10.1016/j.gene.2014.01.029.
195. DiNovo AA, Schey KL, Vachon WS, McGuffie EM, Olson JC, Vincent TS. 2006. ADP-ribosylation of cyclophilin A by Pseudomonas aeruginosa exoenzyme S. Biochemistry (Mosc.) 45:4664-4673. http://dx.doi.org/10.1021/bi0513554.
196. Aulik NA, Hellenbrand KM, Kisiela D, Czuprynski CJ. 2011. Mannheimia haemolytica leukotoxin binds cyclophilin D on bovine neutrophil mitochondria. Microb. Pathog. 50:168-178. http://dx.doi.org/10.1016/j.micpath.2011.01.001.
197. Elrod JW, Molkentin JD. 2013. Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore. Circ. J. 77:1111-1122. http://dx.doi.org/10.1253/circj.CJ-13-0321.
198. Atapattu DN, Albrecht RM, McClenahan DJ, Czuprynski CJ. 2008. Dynamin-2-dependent targeting of Mannheimia haemolytica leukotoxin to mitochondrial cyclophilin D in bovine lymphoblastoid cells. Infect. Immun. 76:5357-5365. http://dx.doi.org/10.1128/IAI.00221-08.
199. Carneiro LAM, Travassos LH, Soares F, Tattoli I, Magalhaes JG, Bozza MT, Plotkowski MC, Sansonetti PJ, Molkentin JD, Philpott DJ, Girardin SE. 2009. Shigella induces mitochondrial dysfunction and cell death in nonmyeloid cells. Cell Host Microbe 5:123-136. http://dx.doi.org/10.1016/j.chom.2008.12.011.
200. Barth H, Aktories K, Popoff MR, Stiles BG. 2004. Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol. Mol. Biol. Rev. 68:373-402. http://dx.doi.org/10.1128/MMBR.68.3.373-402.2004.
201. Dmochewitz L, Lillich M, Kaiser E, Jennings LD, Lang AE, Buchner J, Fischer G, Aktories K, Collier RJ, Barth H. 2011. Role of CypA and Hsp90 in membrane translocation mediated by anthrax protective antigen. Cell. Microbiol. 13:359-373. http://dx.doi.org/10.1111/j.1462-5822.2010.01539.x.
202. Kaiser E, Kroll C, Ernst K, Schwan C, Popoff M, Fischer G, Buchner J, Aktories K, Barth H. 2011. Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90. Infect. Immun. 79:3913-3921. http://dx.doi.org/10.1128/IAI.05372-11.
203. Kaiser E, Böhm N, Ernst K, Langer S, Schwan C, Aktories K, Popoff M, Fischer G, Barth H. 2012. FK506-binding protein 51 interacts with Clostridium botulinum C2 toxin and FK506 inhibits membrane translocation of the toxin in mammalian cells. Cell. Microbiol. 14:1193-1205. http://dx.doi.org/10.1111/j.1462-5822.2012.01788.x.
204. Mahbubani MH, Bej AK, Miller R, Haff L, DiCesare J, Atlas RM. 1990. Detection of Legionella with polymerase chain reaction and gene probe methods. Mol. Cell. Probes 4:175-187. http://dx.doi.org/10.1016/0890-8508(90)90051-Z.
205. Jaulhac B, Nowicki M, Bornstein N, Meunier O, Prevost G, Piemont Y, Fleurette J, Monteil H. 1992. Detection of Legionella spp. in bronchoalveolar lavage fluids by DNA amplification. J. Clin. Microbiol. 30:920-924.
206. Svarrer CW, Uldum SA. 2012. The occurrence of Legionella species other than Legionella pneumophila in clinical and environmental samples in Denmark identified by mip gene sequencing and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Microbiol. Infect. 18:1004-1009. http://dx.doi.org/10.1111/j.1469-0691.2011.03698.x.
207. O'Connell WA, Bangsborg JM, Cianciotto NP. 1995. Characterization of a Legionella micdadei mip mutant. Infect. Immun. 63:2840-2845.
208. Doyle RM, Steele TW, McLennan AM, Parkinson IH, Manning PA, Heuzenroeder MW. 1998. Sequence analysis of the mip gene of the soilborne pathogen Legionella longbeachae. Infect. Immun. 66:1492-1499.
209. Arakaki N, Higa F, Koide M, Tateyama M, Saito A. 2002. Induction of apoptosis of human macrophages in vitro by Legionella longbeachae through activation of the caspase pathway. J. Med. Microbiol. 51:159-168.
210. Mo YY, Cianciotto NP, Mallavia LP. 1995. Molecular cloning of a Coxiella burnetii gene encoding a macrophage infectivity potentiator (Mip) analogue. Microbiology 141:2861-2871. http://dx.doi.org/10.1099/13500872-141-11-2861.
211. Lundemose AG, Birkelund S, Fey SJ, Larsen PM, Christiansen G. 1991. Chlamydia trachomatis contains a protein similar to the Legionella pneumophila mip gene product. Mol. Microbiol. 5:109-115. http://dx.doi.org/10.1111/j.1365-2958.1991.tb01831.x.
212. Rockey DD, Chesebro BB, Heinzen RA, Hackstadt T. 1996. A 28 kDa major immunogen of Chlamydia psittaci shares identity with Mip proteins of Legionella spp. and Chlamydia trachomatis - cloning and characterization of the C. psittaci mip-like gene. Microbiology 142:945-953. http://dx.doi.org/10.1099/00221287-142-4-945.
213. Herrmann M, Schuhmacher A, Mühldorfer I, Melchers K, Prothmann C, Dammeier S. 2006. Identification and characterization of secreted effector proteins of Chlamydophila pneumoniae TW183. Res. Microbiol. 157:513-524. http://dx.doi.org/10.1016/j.resmic.2005.12.005.
214. Marques PX, Souda P, O'Donovan J, Gutierrez J, Gutierrez EJ, Worrall S, McElroy M, Proctor A, Brady C, Sammin D, Basset HF, Whitelegge JP, Markey BE, Nally JE. 2010. Identification of immunologically relevant proteins of Chlamydophila abortus using sera from experimentally infected pregnant ewes. Clin. Vaccine Immunol. 17:1274-1281. http://dx.doi.org/10.1128/CVI.00163-10.
215. Lundemose AG, Rouch DA, Penn CW, Pearce JH. 1993. The Chlamydia trachomatis Mip-like protein is a lipoprotein. J. Bacteriol. 175:3669-3671.
216. Neff L, Daher S, Muzzin P, Spenato U, Gülac¸ar F, Gabay C, Bas S. 2007. Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoprotein. J. Bacteriol. 189:4739-4748. http://dx.doi.org/10.1128/JB.01889-06.
217. Lundemose AG, Kay JE, Pearce JH. 1993. Chlamydia trachomatis Mip-like protein has peptidyl-prolyl cis/trans isomerase activity that is inhibited by FK506 and rapamycin and is implicated in initiation of chlamydial infection. Mol. Microbiol. 7:777-783. http://dx.doi.org/10.1111/j.1365-2958.1993.tb01168.x.
218. Leuzzi R, Serino L, Scarselli M, Savino S, Fontana MR, Monaci E, Taddei A, Fischer G, Rappuoli R, Pizza M. 2005. Ng-MIP, a surface-exposed lipoprotein of Neisseria gonorrhoeae, has a peptidyl-prolyl cis/trans isomerase (PPIase) activity and is involved in persistence in macrophages. Mol. Microbiol. 58:669-681. http://dx.doi.org/10.1111/j.1365-2958.2005.04859.x.
219. Echenique-Rivera H, Muzzi A, Del Tordello E, Seib KL, Francois P, Rappuoli R, Pizza M, Serruto D. 2011. Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival. PLoS Pathog. 7:e1002027. http://dx.doi.org/10.1371/journal.ppat.1002027.
220. Hung M-C, Salim O, Williams JN, Heckels JE, Christodoulides M. 2011. The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate. Infect. Immun. 79:3784-3791. http://dx.doi.org/10.1128/IAI.05019-11.
221. Maeda T, Maeda H, Yamabe K, Mineshiba J, Tanimoto I, Yamamoto T, Naruishi K, Kokeguchi S, Takashiba S. 2010. Highly expressed genes in a rough-colony-forming phenotype of Aggregatibacter actinomycetemcomitans: implication of a mip-like gene for the invasion of host tissue. FEMS Immunol. Med. Microbiol. 58:226-236. http://dx.doi.org/10.1111/j.1574-695X.2009.00624.x.
222. Wong CY, Heuzenroeder MW, Quinn DM, Flower RL. 1997. Cloning and characterization of two immunophilin-like genes, ilpA and fkpA, on a single 3.9-kilobase fragment of Aeromonas hydrophila genomic DNA. J. Bacteriol. 179:3397-3403.
223. Horne SM, Kottom TJ, Nolan LK, Young KD. 1997. Decreased intracellular survival of an fkpA mutant of Salmonella typhimurium Copenhagen. Infect. Immun. 65:806-810.
224. Humphreys S, Rowley G, Stevenson A, Kenyon WJ, Spector MP, Roberts M. 2003. Role of periplasmic peptidylprolyl isomerases in Salmonella enterica serovar Typhimurium virulence. Infect. Immun. 71:5386-5388. http://dx.doi.org/10.1128/IAI.71.9.5386-5388.2003.
225. Rizzitello AE, Harper JR, Silhavy TJ. 2001. Genetic evidence for parallel pathways of chaperone activity in the periplasm of Escherichia coli. J. Bacteriol. 183:6794-6800. http://dx.doi.org/10.1128/JB.183.23.6794-6800.2001.
226. Sklar JG, Wu T, Kahne D, Silhavy TJ. 2007. Defining the roles of the periplasmic chaperones SurA, Skp, and DegP in Escherichia coli. Genes Dev. 21:2473-2484. http://dx.doi.org/10.1101/gad.1581007.
227. Ruiz-Perez F, Henderson IR, Leyton DL, Rossiter AE, Zhang Y, Nataro JP. 2009. Roles of periplasmic chaperone proteins in the biogenesis of serine protease autotransporters of Enterobacteriaceae. J. Bacteriol. 191:6571-6583. http://dx.doi.org/10.1128/JB.00754-09.
228. Ruiz-Perez F, Henderson IR, Nataro JP. 2010. Interaction of FkpA, a peptidyl-prolyl cis/trans isomerase with EspP autotransporter protein. Gut Microbes 1:339-344. http://dx.doi.org/10.4161/gmic.1.5.13436.
229. Zang N, Tang D-J, Wei M-L, He Y-Q, Chen B, Feng J-X, Xu J, Gan Y-Q, Jiang B-L, Tang J-L. 2007. Requirement of a mip-like gene for virulence in the phytopathogenic bacterium Xanthomonas campestris pv. campestris. Mol. Plant Microbe Interact. 20:21-30. http://dx.doi.org/10.1094/MPMI-20-0021.
230. Meng Q-L, Tang D-J, Fan Y-Y, Li Z-J, Zhang H, He Y-Q, Jiang B-L, Lu G-T, Tang J-L. 2011. Effect of interactions between Mip and PrtA on the full extracellular protease activity of Xanthomonas campestris pathovar campestris. FEMS Microbiol. Lett. 323:180-187. http://dx.doi.org/10.1111/j.1574-6968.2011.02377.x.
231. DebRoy S, Keenan AB, Ueno N, Jeronimo SMB, Donelson JE, Wilson ME. 2010. Leishmania infantum chagasi: a genome-based approach to identification of excreted/secreted proteins. Exp. Parasitol. 126:582-591. http://dx.doi.org/10.1016/j.exppara.2010.06.011.
232. Pereira PJB, Vega MC, González-Rey E, Fernández-Carazo R, Macedo-Ribeiro S, Gomis-Rüth FX, González A, Coll M. 2002. Trypanosoma cruzi macrophage infectivity potentiator has a rotamase core and a highly exposed alpha-helix. EMBO Rep. 3:88-94. http://dx.doi.org/10.1093/embo-reports/kvf009.
233. Cianciotto NP, Eisenstein BI, Mody CH, Toews GB, Engleberg NC. 1989. A Legionella pneumophila gene encoding a species-specific surface protein potentiates initiation of intracellular infection. Infect. Immun. 57:1255-1262.
234. Engleberg NC, Carter C, Weber DR, Cianciotto NP, Eisenstein BI. 1989. DNA sequence of mip, a Legionella pneumophila gene associated with macrophage infectivity. Infect. Immun. 57:1263-1270.
235. Cianciotto NP, Fields BS. 1992. Legionella pneumophila mip gene potentiates intracellular infection of protozoa and human macrophages. Proc. Natl. Acad. Sci. U. S. A. 89:5188-5191. http://dx.doi.org/10.1073/pnas.89.11.5188.
236. Wieland H, Faigle M, Lang F, Northoff H, Neumeister B. 2002. Regulation of the Legionella mip-promotor during infection of human monocytes. FEMS Microbiol. Lett. 212:127-132. http://dx.doi.org/10.1111/j.1574-6968.2002.tb11255.x.
237. Shi C, Forsbach-Birk V, Marre R, McNealy TL. 2006. The Legionella pneumophila global regulatory protein LetA affects DotA and Mip. Int. J. Med. Microbiol. 296:15-24. http://dx.doi.org/10.1016/j.ijmm.2005.09.003.
238. Riboldi-Tunnicliffe A, König B, Jessen S, Weiss MS, Rahfeld J, Hacker J, Fischer G, Hilgenfeld R. 2001. Crystal structure of Mip, a prolylisomerase from Legionella pneumophila. Nat. Struct. Biol. 8:779-783. http://dx.doi.org/10.1038/nsb0901-779.
239. Horstmann M, Ehses P, Schweimer K, Steinert M, Kamphausen T, Fischer G, Hacker J, Rösch P, Faber C. 2006. Domain motions of the Mip protein from Legionella pneumophila. Biochemistry (Mosc.) 45:12303-12311. http://dx.doi.org/10.1021/bi060818i.
240. Ceymann A, Horstmann M, Ehses P, Schweimer K, Paschke A-K, Steinert M, Faber C. 2008. Solution structure of the Legionella pneumophila Mip-rapamycin complex. BMC Struct. Biol. 8:17. http://dx.doi.org/10.1186/1472-6807-8-17.
241. Schmidt B, Rahfeld J, Schierhorn A, Ludwig B, Hacker J, Fischer G. 1994. A homodimer represents an active species of the peptidyl-prolyl cis/trans isomerase FKBP25mem from Legionella pneumophila. FEBS Lett. 352:185-190. http://dx.doi.org/10.1016/0014-5793(94)00970-8.
242. Budiman C, Bando K, Angkawidjaja C, Koga Y, Takano K, Kanaya S. 2009. Engineering of monomeric FK506-binding protein 22 with peptidyl prolyl cis-trans isomerase. Importance of a V-shaped dimeric structure for binding to protein substrate. FEBS J. 276:4091-4101. http://dx.doi.org/10.1111/j.1742-4658.2009.07116.x.
243. Wintermeyer E, Ludwig B, Steinert M, Schmidt B, Fischer G, Hacker J. 1995. Influence of site specifically altered Mip proteins on intracellular survival of Legionella pneumophila in eukaryotic cells. Infect. Immun. 63:4576-4583.
244. Köhler R, Fanghänel J, König B, Lüneberg E, Frosch M, Rahfeld J-U, Hilgenfeld R, Fischer G, Hacker J, Steinert M. 2003. Biochemical and functional analyses of the Mip protein: influence of the N-terminal half and of peptidylprolyl isomerase activity on the virulence of Legionella pneumophila. Infect. Immun. 71:4389-4397. http://dx.doi.org/10.1128/IAI.71.8.4389-4397.2003.
245. Cianciotto NP, Eisenstein BI, Mody CH, Engleberg NC. 1990. A mutation in the mip gene results in an attenuation of Legionella pneumophila virulence. J. Infect. Dis. 162:121-126. http://dx.doi.org/10.1093/infdis/162.1.121.
246. Wagner C, Khan AS, Kamphausen T, Schmausser B, Unal C, Lorenz U, Fischer G, Hacker J, Steinert M. 2007. Collagen binding protein Mip enables Legionella pneumophila to transmigrate through a barrier of NCI-H292 lung epithelial cells and extracellular matrix. Cell. Microbiol. 9:450-462. http://dx.doi.org/10.1111/j.1462-5822.2006.00802.x.
247. Ünal C, Schwedhelm KF, Thiele A, Weiwad M, Schweimer K, Frese F, Fischer G, Hacker J, Faber C, Steinert M. 2011. Collagen IV-derived peptide binds hydrophobic cavity of Legionella pneumophila Mip and interferes with bacterial epithelial transmigration. Cell. Microbiol. 13:1558-1572. http://dx.doi.org/10.1111/j.1462-5822.2011.01641.x.
248. Galka F, Wai SN, Kusch H, Engelmann S, Hecker M, Schmeck B, Hippenstiel S, Uhlin BE, Steinert M. 2008. Proteomic characterization of the whole secretome of Legionella pneumophila and functional analysis of outer membrane vesicles. Infect. Immun. 76:1825-1836. http://dx.doi.org/10.1128/IAI.01396-07.
249. Cameron AM, Steiner JP, Roskams AJ, Ali SM, Ronnett GV, Snyder SH. 1995. Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux. Cell 83:463-472. http://dx.doi.org/10.1016/0092-8674(95)90124-8.
250. Cameron AM, Nucifora FC, Jr, Fung ET, Livingston DJ, Aldape RA, Ross CA, Snyder SH. 1997. FKBP12 binds the inositol 1,4,5-trisphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FK506-like domain. J. Biol. Chem. 272:27582-27588. http://dx.doi.org/10.1074/jbc.272.44.27582.
251. Lam D, Golstein P. 2008. A specific pathway inducing autophagic cell death is marked by an IP3R mutation. Autophagy 4:349-350. http://dx.doi.org/10.4161/auto.5521.
252. Lam D, Kosta A, Luciani M-F, Golstein P. 2008. The inositol 1,4,5-trisphosphate receptor is required to signal autophagic cell death. Mol. Biol. Cell 19:691-700. http://dx.doi.org/10.1091/mbc.E07-08-0823.
253. Amer AO, Swanson MS. 2005. Autophagy is an immediate macrophage response to Legionella pneumophila. Cell. Microbiol. 7:765-778. http://dx.doi.org/10.1111/j.1462-5822.2005.00509.x.
254. Farbrother P, Wagner C, Na J, Tunggal B, Morio T, Urushihara H, Tanaka Y, Schleicher M, Steinert M, Eichinger L. 2006. Dictyostelium transcriptional host cell response upon infection with Legionella. Cell. Microbiol. 8:438-456. http://dx.doi.org/10.1111/j.1462-5822.2005.00633.x.
255. Debroy S, Aragon V, Kurtz S, Cianciotto NP. 2006. Legionella pneumophila Mip, a surface-exposed peptidylproline cis-trans-isomerase, promotes the presence of phospholipase C-like activity in culture supernatants. Infect. Immun. 74:5152-5160. http://dx.doi.org/10.1128/IAI.00484-06.
256. Shahnazari S, Yen W-L, Birmingham CL, Shiu J, Namolovan A, Zheng YT, Nakayama K, Klionsky DJ, Brumell JH. 2010. A diacylglycerol-dependent signaling pathway contributes to regulation of antibacterial autophagy. Cell Host Microbe 8:137-146. http://dx.doi.org/10.1016/j.chom.2010.07.002.
257. Weber SS, Ragaz C, Reus K, Nyfeler Y, Hilbi H. 2006. Legionella pneumophila exploits PI(4)P to anchor secreted effector proteins to the replicative vacuole. PLoS Pathog. 2:e46. http://dx.doi.org/10.1371/journal.ppat.0020046.
258. Viner R, Chetrit D, Ehrlich M, Segal G. 2012. Identification of two Legionella pneumophila effectors that manipulate host phospholipids biosynthesis. PLoS Pathog. 8:e1002988. http://dx.doi.org/10.1371/journal.ppat.1002988.
259. Schunder E, Adam P, Higa F, Remer KA, Lorenz U, Bender J, Schulz T, Flieger A, Steinert M, Heuner K. 2010. Phospholipase PlaB is a new virulence factor of Legionella pneumophila. Int. J. Med. Microbiol. 300:313-323. http://dx.doi.org/10.1016/j.ijmm.2010.01.002.
260. Gan Y-H. 2005. Interaction between Burkholderia pseudomallei and the host immune response: sleeping with the enemy? J. Infect. Dis. 192:1845-1850. http://dx.doi.org/10.1086/497382.
261. Norville IH, Harmer NJ, Harding SV, Fischer G, Keith KE, Brown KA, Sarkar-Tyson M, Titball RW. 2011. A Burkholderia pseudomallei macrophage infectivity potentiator-like protein has rapamycin-inhibitable peptidylprolyl isomerase activity and pleiotropic effects on virulence. Infect. Immun. 79:4299-4307. http://dx.doi.org/10.1128/IAI.00134-11.
262. Norville IH, Breitbach K, Eske-Pogodda K, Harmer NJ, Sarkar-Tyson M, Titball RW, Steinmetz I. 2011. A novel FK-506-binding-like protein that lacks peptidyl-prolyl isomerase activity is involved in intracellular infection and in vivo virulence of Burkholderia pseudomallei. Microbiology 157:2629-2638. http://dx.doi.org/10.1099/mic.0.049163-0.
263. Norville IH, O'Shea K, Sarkar-Tyson M, Zheng S, Titball RW, Varani G, Harmer NJ. 2011. The structure of a Burkholderia pseudomallei immunophilin-inhibitor complex reveals new approaches to antimicrobial development. Biochem. J. 437:413-422. http://dx.doi.org/10.1042/BJ20110345.
264. Lynch SV, Wiener-Kronish JP. 2008. Novel strategies to combat bacterial virulence. Curr. Opin. Crit. Care 14:593-599. http://dx.doi.org/10.1097/MCC.0b013e32830f1dd5.
265. Cusumano CK, Hultgren SJ. 2009. Bacterial adhesion - a source of alternate antibiotic targets. IDrugs 12:699-705.
266. Baron C. 2010. Antivirulence drugs to target bacterial secretion systems. Curr. Opin. Microbiol. 13:100-105. http://dx.doi.org/10.1016/j.mib.2009.12.003.
267. Sintim HO, Smith JAI, Wang J, Nakayama S, Yan L. 2010. Paradigm shift in discovering next-generation anti-infective agents: targeting quorum sensing, c-di-GMP signaling and biofilm formation in bacteria with small molecules. Future Med. Chem. 2:1005-1035. http://dx.doi.org/10.4155/fmc.10.185.
268. Van Duyne GD, Standaert RF, Karplus PA, Schreiber SL, Clardy J. 1991. Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. Science 252:839-842. http://dx.doi.org/10.1126/science.1709302.
269. Babine RE, Bender SL. 1997. Molecular recognition of protein-ligand complexes: applications to drug design. Chem. Rev. 97:1359-1472. http://dx.doi.org/10.1021/cr960370z.
270. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H. 1987. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J. Antibiot. (Tokyo) 40:1249-1255.
271. Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki H. 1987. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J. Antibiot. (Tokyo) 40:1256-1265.
272. Arai T, Kouama Y, Suenaga T, Honda H. 1962. Ascomycin, an antifungal antibiotic. J. Antibiot. (Tokyo) 15:231-232.
273. Sehgal SN, Baker H, Vézina C. 1975. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J. Antibiot. (Tokyo) 28:727-732.
274. Hatanaka H, Kino T, Miyata S, Inamura N, Kuroda A, Goto T, Tanaka H, Okuhara M. 1988. FR-900520 and FR-900523, novel immunosuppressants isolated from a Streptomyces. II. Fermentation, isolation and physico-chemical and biological characteristics. J. Antibiot. (Tokyo) 41:1592-1601.
275. Wang XJ, Etzkorn FA. 2006. Peptidyl-prolyl isomerase inhibitors. Biopolymers 84:125-146. http://dx.doi.org/10.1002/bip.20240.
276. Bierer BE, Somers PK, Wandless TJ, Burakoff SJ, Schreiber SL. 1990. Probing immunosuppressant action with a nonnatural immunophilin ligand. Science 250:556-559. http://dx.doi.org/10.1126/science.1700475.
277. Bierer BE, Mattila PS, Standaert RF, Herzenberg LA, Burakoff SJ, Crabtree G, Schreiber SL. 1990. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc. Natl. Acad. Sci. U. S. A. 87:9231-9235. http://dx.doi.org/10.1073/pnas.87.23.9231.
278. Liu J, Farmer JD, Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-815. http://dx.doi.org/10.1016/0092-8674(91)90124-H.
279. Chiu MI, Katz H, Berlin V. 1994. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. Proc. Natl. Acad. Sci. U. S. A. 91:12574-12578. http://dx.doi.org/10.1073/pnas.91.26.12574.
280. Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, Wiederrecht G, Abraham RT. 1995. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J. Biol. Chem. 270:815-822. http://dx.doi.org/10.1074/jbc.270.2.815.
281. Van Duyne GD, Standaert RF, Karplus PA, Schreiber SL, Clardy J. 1993. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J. Mol. Biol. 229:105-124. http://dx.doi.org/10.1006/jmbi.1993.1012.
282. Aldape RA, Futer O, DeCenzo MT, Jarrett BP, Murcko MA, Livingston DJ. 1992. Charged surface residues of FKBP12 participate in formation of the FKBP12-FK506-calcineurin complex. J. Biol. Chem. 267:16029-16032.
283. Holt DA, Luengo JI, Yamashita DS, Oh HJ, Konialian AL, Yen HK, Rozamus LW, Brandt M, Bossard MJ. 1993. Design, synthesis, and kinetic evaluation of high-affinity FKBP ligands and the X-ray crystal structures of their complexes with FKBP12. J. Am. Chem. Soc. 115:9925-9938. http://dx.doi.org/10.1021/ja00075a008.
284. Armistead DM, Badia MC, Deininger DD, Duffy JP, Saunders JO, Tung RD, Thomson JA, DeCenzo MT, Futer O, Livingston DJ, Murcko MA, Yamashita MM, Navia MA. 1995. Design, synthesis and structure of nonmacrocyclic inhibitors of FKBP12, the major binding protein for the immunosuppressant FK506. Acta Crystallogr. D Biol. Crystallogr. 51:522-528. http://dx.doi.org/10.1107/S0907444994014502.
285. Tatlock JH, Kalish VJ, Parge HE, Knighton DR, Showalter RE, Lewis CT, French JV, Villafranca JE. 1995. High-affinity FKBP-12 ligands derived from (R)-(-)-carvone. Synthesis and evaluation of FK506 pyranose ring replacements. Bioorg. Med. Chem. Lett. 5:2489-2494. http://dx.doi.org/10.1016/0960-894X(95)00429-W.
286. Babine RE, Bleckman TM, Kissinger CR, Showalter R, Pelletier LA, Lewis C, Tucker K, Moomaw E, Parge HE, Villafranca JE. 1995. Design, synthesis and X-ray crystallographic studies of novel FKBP-12 ligands. Bioorg. Med. Chem. Lett. 5:1719-1724. http://dx.doi.org/10.1016/0960-894X(95)00290-A.
287. Hauske JR, Dorff P, Julin S, DiBrino J, Spencer R, Williams R. 1992. Design and synthesis of novel FKBP inhibitors. J. Med. Chem. 35:4284-4296. http://dx.doi.org/10.1021/jm00101a005.
288. Andres CJ, Macdonald TL, Ocain TD, Longhi D. 1993. Conformationally defined analogs of prolylamides. trans-Prolyl peptidomimetics. J. Org. Chem. 58:6609-6613. http://dx.doi.org/10.1021/jo00076a018.
289. Burkhard P, Hommel U, Sanner M, Walkinshaw MD. 1999. The discovery of steroids and other novel FKBP inhibitors using a molecular docking program. J. Mol. Biol. 287:853-858. http://dx.doi.org/10.1006/jmbi.1999.2621.
290. Christner C, Wyrwa R, Marsch S, Küllertz G, Thiericke R, Grabley S, Schumann D, Fischer G. 1999. Synthesis and cytotoxic evaluation of cycloheximide derivatives as potential inhibitors of FKBP12 with neuroregenerative properties. J. Med. Chem. 42:3615-3622. http://dx.doi.org/10.1021/jm991038t.
291. Juli C, Sippel M, Jäger J, Thiele A, Weiwad M, Schweimer K, Rösch P, Steinert M, Sotriffer CA, Holzgrabe U. 2011. Pipecolic acid derivatives as small-molecule inhibitors of the Legionella MIP protein. J. Med. Chem. 54:277-283. http://dx.doi.org/10.1021/jm101156y.
292. Holt DA, Konialian-Beck AL, Oh H-J, Yen H-K, Rozamus LW, Krog AJ, Erhard KF, Ortiz E, Levy MA, Brandt M, Bossard MJ, Luengo JI. 1994. Structure-activity studies of synthetic FKBP ligands as peptidylprolyl isomerase inhibitors. Bioorg. Med. Chem. Lett. 4:315-320. http://dx.doi.org/10.1016/S0960-894X(01)80135-9.
293. Monaghan P, Fardis M, Revill WP, Bell A. 2005. Antimalarial effects of macrolactones related to FK520 (ascomycin) are independent of the immunosuppressive properties of the compounds. J. Infect. Dis. 191:1342-1349. http://dx.doi.org/10.1086/428454.
294. Harikishore A, Niang M, Rajan S, Preiser PR, Yoon HS. 2013. Small molecule Plasmodium FKBP35 inhibitor as a potential antimalaria agent. Sci. Rep. 3:2501. http://dx.doi.org/10.1038/srep02501.
295. Fischer G, Tradler T, Zarnt T. 1998. The mode of action of peptidyl prolyl cis/trans isomerases in vivo: binding vs. catalysis. FEBS Lett. 426:17-20. http://dx.doi.org/10.1016/S0014-5793(98)00242-7.
296. Lundemose AG, Rouch DA, Birkelund S, Christiansen G, Pearce JH. 1992. Chlamydia trachomatis Mip-like protein. Mol. Microbiol. 6:2539-2548.